Skip to content
Disclosery

EXANE DERIVATIVES: MA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,015 MA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,015 shares
    Change vs previous 13F -860 shares

    0.18% of the 13F portfolio, value $320,147.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,875 shares
    Change vs previous 13F -203 shares

    0.19% of the 13F portfolio, value $670,092.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,078 shares
    Change vs previous 13F -970 shares

    0.18% of the 13F portfolio, value $746,691.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,048 shares
    Change vs previous 13F -188 shares

    0.26% of the 13F portfolio, value $1,059,770.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,236 shares
    Change vs previous 13F +1,522 shares

    0.29% of the 13F portfolio, value $1,241,713.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,714 shares
    Change vs previous 13F +132 shares

    0.18% of the 13F portfolio, value $610,298.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,582 shares
    Change vs previous 13F +915 shares

    0.17% of the 13F portfolio, value $564,704.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 667 shares
    Change vs previous 13F not available

    0.07% of the 13F portfolio, value $225,565.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).